Generation Bio Co.
GBIO
$6.35
$0.223.59%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -91.23% | 108.29% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -91.23% | 108.29% | |||
| Cost of Revenue | 2.50% | -3.73% | |||
| Gross Profit | -272.97% | 62.27% | |||
| SG&A Expenses | -10.59% | 0.94% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.23% | -1.38% | |||
| Operating Income | -44.83% | 23.96% | |||
| Income Before Tax | -41.35% | 30.77% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -41.35% | 30.77% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -41.35% | 30.77% | |||
| EBIT | -44.83% | 23.96% | |||
| EBITDA | -48.40% | 25.22% | |||
| EPS Basic | -41.28% | 30.99% | |||
| Normalized Basic EPS | -49.29% | 25.00% | |||
| EPS Diluted | -41.28% | 30.99% | |||
| Normalized Diluted EPS | -49.29% | 25.00% | |||
| Average Basic Shares Outstanding | 0.05% | 0.32% | |||
| Average Diluted Shares Outstanding | 0.05% | 0.32% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||